Skip to content
CancerIndex

Publication

De-escalation trials in multiple myeloma: past, present and future.

Hira Mian, Luciano J Costa, Mohamad Mohty, Alfred Garfall, S Vincent Rajkumar

Nature reviews. Clinical oncologyOct 1, 2026PMID 42527555doi:10.1038/s41571-026-01186-3 Journal ArticleReviewpubmedProvenance
Source
PubMed
Retrieved
Oct 1, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20261001-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

De-escalation of therapy constitutes a new phase in the development of therapeutic approaches for patients with multiple myeloma (MM) and is aimed at maintaining durable disease control while reducing the toxicity and burden associated with prolonged treatment. Given that increasingly effective…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.